Back |
home / stock / ppcb / ppcb message board
Subject | By | Source | When |
---|---|---|---|
Thats the problem. Flippers will be Flipping all | invader Zim | investorshub | 04/27/2023 3:45:35 PM |
+>>>>$PPCB - At these prices... a couple ticks | Chrion Capital | investorshub | 04/27/2023 3:42:29 PM |
+>>>$PPCB - Weeeeeeeeeeeeeeee | Chrion Capital | investorshub | 04/27/2023 3:40:12 PM |
Waiting and waiting and waiting. But it could | linkvest | investorshub | 04/27/2023 2:53:03 PM |
Don't remember the names of the places but | linkvest | investorshub | 04/27/2023 2:52:01 PM |
I guess folks are waiting for PR, low volume | invader Zim | investorshub | 04/27/2023 2:50:07 PM |
Sponge Docks is great food! I also | Da Stock Alpaca | investorshub | 04/27/2023 2:43:20 PM |
I am waiting for the right time to | RMS555 | investorshub | 04/27/2023 2:29:39 PM |
wasting my time trying to read to see | RMS555 | investorshub | 04/27/2023 2:23:23 PM |
It's kind of boring watching the lack lackluster | nwsun | investorshub | 04/27/2023 2:05:13 PM |
I'd take basic and not interesting people over | linkvest | investorshub | 04/27/2023 1:19:18 PM |
Hope today isn't as exciting as yesterday lol... | linkvest | investorshub | 04/27/2023 1:10:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Propanc Biopharma Inc Company Name:
PPCB Stock Symbol:
OTCMKTS Market:
Propanc Biopharma Inc Website:
British Journal of Cancer Concludes Tumor cell-intrinsic PD-L1 function promotes EMT Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recu...
Certificate of Grant Received for “Cancer Treatment” Patent from IP Corporation of Malaysia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patient...
Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s &...